A writeup of KV this morning:
"In the meantime, Imperial Capital believes K-V must try to renegotiate upcoming licensing payments to Hologic, Makena’s originator, which represent a large near-term liability. This might help delay the cash crunch, as might cutting operating costs. [...] Just how much headroom there is for further price reductions, and whether these might do anything to change the FDA’s stance, are two key issues with which the company must now grapple, assuming that it is not already too late. To be sure the grim reaper is now knocking at K-V’s door."Just took a look at the latest in the FDA lawsuit - the defendants (FDA) are to file the Administrative Record by 8/10/2012. Also, with regard to KV's motion for temporary restraining order and preliminary injunction:
"defendants' dispositive motion and combined memorandum in opposition to plaintiffs' motion and in support of its dispositive motion shall be filed on or before July 20, 2012; plaintiffs' combined reply and opposition to the dispositive motion shall be filed on or before July 27, 2012; defendants' reply in support of its dispositive motion shall be filed on or before August 3, 2012; and a motions hearing is set for August 7, 2012, at 2:00 pm. Since plaintiffs' motion is now consolidated with the merits, the parties need not brief irreparable harm."So it looks like it will be about a month before there is even the possibility of a positive news catalyst.